vimarsana.com

Latest Breaking News On - Acta pharmacologica sinica - Page 1 : vimarsana.com

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to Dr. Quigley, who addresses the importance of identifying and reducing residual inflammatory risk.

How much does it cost to get a scientific paper?

The Backstory:  As it stands today,when one of the National Institutes of Health (NIH) provides the funding for a scientific research project, and those results are published, they must be made freely available to public, within a set period of time.  The reasoning behind this requirement is that taxpayers funded everything about the research except for the final publication, and so they have already paid for access.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.